Shenzhen Bioeasy Biotechnology (SZ:300942) Sou Hu Cai Jing·2025-09-17 02:41Group 1 - The core point of the news is that Yirui Biotech (300942) has seen a net financing inflow of 1.2464 million yuan on September 16, 2025, with a total financing balance of 12.4 million yuan, indicating a positive trend in investor interest [1][2][3] - Over the past three trading days, Yirui Biotech has accumulated a total net financing inflow of 8.5445 million yuan, suggesting a growing confidence among investors [1] - In the last 20 trading days, there have been 11 days with net financing inflows, reflecting a consistent demand for the company's shares [1] Group 2 - The financing balance on September 16, 2025, increased by 1.02% compared to the previous day, indicating a slight upward trend in the overall financing activity [3] - The financing balance on September 15, 2025, was 1.23 billion yuan, which also showed a 1.54% increase from the previous day [3] - The financing net inflow on September 12, 2025, was the highest in the observed period at 5.4529 million yuan, highlighting a peak in investor activity [2][3]